Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study. Hassing CMS, Mejdahl MK, Laenkholm AV, Kroman N, et al. Breast Cancer Res Treat 2022 Dec 28. doi: 10.1007/s10549-022-06839.

Read + Share

Amedeo Smart

Independent Medical Education

Hassing CMS, Mejdahl MK, Laenkholm AV, Kroman N, et al. Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study. Breast Cancer Res Treat 2022 Dec 28. doi: 10.1007/s10549-022-06839.
PMID: 36576678